← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS TOTOWA · Approved 2012-08-08

Drug application

FDA Application #

ANDA078803

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

Oxaliplatin

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACTAVIS TOTOWA

First approval

2012-08-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown